<DOC>
	<DOCNO>NCT02318875</DOCNO>
	<brief_summary>Joints muscle disorder common symptom population . They characterize swell , pain , functional impairment morning stiffness . These disorder really disable painful , affect person 's quality life . The purpose clinical trial test Kritech ( Krill oil ) efficacy reduce symptom 154 subject complain functional discomfort associate joint muscle disorder .</brief_summary>
	<brief_title>Investigation Kritech Efficacy Subjects Having Functional Discomfort Associated Joints Muscles Disorders</brief_title>
	<detailed_description>Epidemiological study prevalence incidence joint muscle disorder scare . Two epidemiological French study record patient consult GP widespread pain , whatever cause . The often cite pain localization musculoskeletal system ( 36-59 % case ) . In Europe situation similar , arthritis osteoarthritis represent 42 % pain . According WHO ( World Health Organization ) musculoskeletal system 's disorder first cause handicap worldwide population . Krill oil low saturate fatty acid monounsaturated fatty acid high polyunsaturated fatty acid include high proportion ( n-3 ) fatty acid particularly EPA DHA . There strong evidence krill oil may improve comfort sensitive joint thank n-3 fatty acid phospholipid content . Particularly , supplementation dietary product contain pure krill oil , reduction systemic inflammation , trough reduction CRP , concomitantly accompany improvement various clinical score associate joint flexibility , comfort function . Despite , study yet healthy volunteer complain symptom rheumatologic pathology , without ill . Here perform clinical trial 154 subject complain functional discomfort associate joint muscle disorder . The principal objective test Kritech efficacy reduce symptom . Subjects split two group , one receiving Kritech second one placebo 12 week .</detailed_description>
	<mesh_term>Muscular Diseases</mesh_term>
	<criteria>Male female subject ; &gt; 18 year old ; Complaining functional discomfort associate joint and/or muscle disorder , motility disorder and/or initial SMFA score high equal 15 ; Able give write verbal informed consent , Affiliated beneficiary social security IMC &gt; 30kg/m Acute chronic , progressive joint disorder ( arthrosis , rheumatoid arthritis , acute articular rheumatism ) first second degree correlate treatment ; Subjects refuse give write verbal informed consent Subjects deprive freedom follow administrative judicial decision Participation another clinical trial last four week ; People already participate another research comprise exclusion period still ongoing time inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Inflammation</keyword>
	<keyword>swell</keyword>
	<keyword>pain</keyword>
	<keyword>functional impairment</keyword>
	<keyword>stiffness</keyword>
</DOC>